mechanism of action of glp 1 agonists Possible mechanisms glucagon-like peptide-1 receptor on blood pressure beyond body weight GLP-1 Receptor Agonists as Treatments

( Food addiction is one of the major components of the obesogenic set of forces deeply rooted in our society

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis

A phase 2, 16-week, open-label study in 18 subjects ranging from 6 to 40 years of age results in a mean BMI reduction of 18% in those younger than 18 years, and 6% for those 18 years or older, accompanied by significant reduction of hunger scores (127)

It acts on the brains appetite centers, leading to reduced food intake and increased satiety

While mild gastrointestinal symptoms are expected with GLP-1 agonist therapy, certain presentations warrant prompt medical evaluation

N Engl J Med 2009;361:2019-32.PubMed 12